| Compounds | BChE IC50 (μM) | BChE-ligands interactions | |||
|---|---|---|---|---|---|
| 4h | −9.52 | O72 | OD1-ASP283 | HBD | 2.38 |
| O72 | OD2-ASP283 | HBD | 2.30 | ||
| C42 | 6-Ring-TYR332 | H–π | 2.70 | ||
| 6-Ring | 5-Ring-TRP82 | π–π | 2.61 | ||
| SM3 | −7.15 | N41 | O-SER287 | HBD | 2.14 |
| O30 | N-GLY115 | HBA | 2.39 | ||
| 4i | −6.98 | S11 | OG-SER198 | HBA | 2.12 |
| C8 | 5-Ring-TRP82 | H–π | 2.81 | ||
| Galantamine | −6.66 | O18 | OE2-GLU197 | HBD | 2.76 |
| O18 | N-GLY116 | HBA | 2.04 | ||
| 4k | −4.12 | S11 | OG-SER198 | HBA | 2.51 |
| 6-Ring | CE1-PHE329 | H–π | 2.94 | ||
| 4q | −3.36 | S11 | OG-SER198 | HBA | 2.52 |
| 6-Ring | CB-ASN68 | H–π | 2.56 | ||